Correspondence on 'SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response'.
Ann Rheum Dis
; 80(10): e162, 2021 Oct.
Article
in English
| MEDLINE | ID: covidwho-1316930
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Immunocompromised Host
/
Rituximab
/
Immunogenicity, Vaccine
/
COVID-19 Vaccines
/
COVID-19
Topics:
Vaccines
Limits:
Adult
/
Female
/
Humans
/
Male
Language:
English
Journal:
Ann Rheum Dis
Year:
2021
Document Type:
Article
Affiliation country:
Annrheumdis-2021-220756
Similar
MEDLINE
...
LILACS
LIS